Teva Pharmaceutical Industries Ltd (TEVA :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
TEVA FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & More 18 Jun 2013 - CNBC.com
-
Teva Pharma buying MicroDose Therapeutx for $40M 17 Jun 2013 - The Associated Press
-
U.S. judge approves FDA plan to drop limits on morning after pill 12 Jun 2013 - Reuters
-
Dow Ends Below 15000, Logs First 3-Day Drop in 2013 12 Jun 2013 - CNBC.com
-
Pfizer Wins in $2.15 Billion Patent Infringement Case 12 Jun 2013 - CNBC.com
-
Plan-B for All-No Age Limits on Morning-After Pill 11 Jun 2013 - Reuters
-
Momenta Pharma rises following upgrade from UBS 06 Jun 2013 - The Associated Press
-
Sector Snap: Makers of morning-after pill rise 06 Jun 2013 - The Associated Press
-
ANALYSIS-After tech success, Israel seeks life sciences growth 06 Jun 2013 - Reuters
MORE FROM CNBC
-
After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & More 18 Jun 2013 - CNBC.com
-
Dow Ends Below 15000, Logs First 3-Day Drop in 2013 12 Jun 2013 - CNBC.com
-
Pfizer Wins in $2.15 Billion Patent Infringement Case 12 Jun 2013 - CNBC.com
MORE FROM OUR PARTNERS
-
Galena Biopharma: David Battles Goliath 10 hrs ago - Seeking Alpha
-
Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy? 13 Jun 2013 - Seeking Alpha
-
Valuing Alexza After The Teva Adasuve Deal 13 Jun 2013 - Seeking Alpha
-
Efficiently Accessing The Companies Behind Israel's Dynamic Economy 13 Jun 2013 - Seeking Alpha
-
3 Drug Manufacturers With Encouraging Receivables 12 Jun 2013 - Seeking Alpha
-
Wednesday's Biotech Catalyst Trade Watch List 12 Jun 2013 - Seeking Alpha
-
Cramer's Mad Money - Lululemon's Worst Moment (6/11/13) 12 Jun 2013 - Seeking Alpha
-
Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big P... 05 Jun 2013 - Seeking Alpha
-
The 10 x 10 Concept For Choosing Dividend Stocks 29 May 2013 - Seeking Alpha
-
Abrams Capital Management Is Bullish On Consumer Finance & More 29 May 2013 - Seeking Alpha
PRESS RELEASES
-
Research Abstracts, Phase 2 Results, and Market Availability of Formul... 15 hrs ago - PR Newswire
-
Teva Strengthens Respiratory Franchise with Acquisition of MicroDose T... 17 Jun 2013 - Business Wire
-
Teva Announces AZILECT® (Rasagiline Tablets) Data to Be Presented at t... 14 Jun 2013 - Business Wire
-
Prize4Life and Knopp Neurosciences Announce Donation of EMPOWER Phase ... 13 Jun 2013 - Business Wire
-
Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis ... 13 Jun 2013 - Business Wire
-
Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Con... 12 Jun 2013 - Business Wire
-
IATI-BioMed 2013: Digital Age Revolutionizing Life Sciences 12 Jun 2013 - Business Wire
-
Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Ge... 12 Jun 2013 - Business Wire
-
Teva and Active Biotech Report Positive Results from Phase IIa Study o... 12 Jun 2013 - Business Wire
-
New Studies, Regulatory Submissions, and Leadership Changes - Research... 10 Jun 2013 - PR Newswire
